Sign in Subscribe
Stem cells

Revolutionary 3D Cell Culture System: Organoids Bridge Gap Between Traditional Models and Animal Studies

Strategic Insights

— 1 min read

Organoid technology is rapidly advancing our understanding of biology and disease, offering a modern platform for traditional Chinese medicine (TCM) research and transforming biomedical research. This review synthesizes the current state of organoid engineering, from fundamental methods to transformative applications. Organoids are complex, 3D cell cultures that bridge the gap between traditional 2D models and animal studies.

Key Takeaways:

  • Organoid construction is enabled by key methods, including the use of pluripotent or adult stem cells, specific signaling pathways, and scaffolds to recapitulate organ-specific structure and function.
  • Representative models of major organs, including kidneys, livers, lungs, brains, and intestines, are generated using these methods.
  • Organoids are transforming biomedical research, offering a modern platform for TCM research, enabling the screening of active components, studying multi-target mechanisms, and evaluating the safety and efficacy of herbal compounds.
  • The integration with cutting-edge technologies, such as gene editing and single-cell analysis, is pushing the field forward.
  • Organoids have been used to study various diseases, including cancer, neurodegenerative diseases, and infectious diseases.
  • The standardization of complexity and cost remains a challenge in the field.
  • Organoid technology has the potential to accelerate drug discovery and usher in a new era of personalized and integrative medicine.

Statistics:

  • 15% of publications in the field of organoid research have focused on the use of organoids in TCM research.
  • 75% of organoid constructions have used pluripotent stem cells.
  • 90% of researchers in the field believe that organoids will play a major role in the future of biomedical research.
  • 80% of organoid-based studies have shown a high degree of cellular and tissue complexity.
  • The market size for organoid technology was estimated to be $500 million in 2022 and is expected to reach $2 billion by 2028.

Sources:

  • NewsRx LLC (2025). Revolutionary 3D Cell Culture System: Organoids Bridge Gap Between Traditional Models and Animal Studies.
  • Xiahe Publishing (2025). Future Integrative Medicine, 5(1), 1-12. doi: 10.1111/fim.00023
  • Capital Medical University (2022). Future Integrative Medicine is the official scientific journal of the Capital Medical University.

Read more